Quick Answer
Apyx Medical Corp reported Stockholders Equity of $14.54 million for fiscal year 2025.
Apyx Medical Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $14.54M | +2.3% |
| 2024 | $14.21M | -46.8% |
| 2023 | $26.70M | -29.0% |
| 2022 | $37.58M | -30.0% |
| 2021 | $53.70M | -15.7% |
| 2020 | $63.72M | -10.6% |
| 2019 | $71.26M | -14.0% |
| 2019 | $82.83M | -5.0% |
| 2018 | $87.18M | -3.8% |
| 2018 | $90.60M | +311.2% |
| 2017 | $22.03M | -16.0% |
| 2016 | $26.22M | +12.0% |
| 2015 | $23.40M | +1456.1% |
| 2014 | $1.50M | -92.1% |
| 2013 | $19.07M | -16.7% |
| 2012 | $22.89M | +3.5% |
| 2011 | $22.12M | +1.6% |
| 2010 | $21.77M | +3.5% |
| 2009 | $21.03M | +4.0% |
| 2008 | $20.22M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.85M | -47.0% | -19.4% |
| June 30, 2025 | $7.25M | -50.8% | -31.0% |
| March 31, 2025 | $10.51M | -48.1% | -26.0% |
| December 31, 2024 | $14.21M | -46.8% | +28.7% |
| September 30, 2024 | $11.04M | -66.9% | -25.1% |
| June 30, 2024 | $14.75M | -59.7% | -27.2% |
| March 31, 2024 | $20.25M | -43.8% | -24.1% |
| December 31, 2023 | $26.70M | -29.0% | -19.9% |
- Apyx Medical Corp showed an increase of +2.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, Apyx Medical Corp’s stockholders equity has declined by 28.1% (from $20.22 million to $14.54 million).
- The most recent figure is from Apyx Medical Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: